Sec Form 13G Filing - Qiming Corporate GP IV, Ltd. filing for - 2025-08-12

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  Note to Row (5) (7) and (9): As of the date of this 13G/A filing, Qiming Corporate GP IV, Ltd. is the general partner of Qiming Managing Directors Fund IV, L.P. and Qiming GP IV, L.P. Qiming Managing Directors Fund IV, L.P. holds approximately 3.06% of the equity interest of QM11 Limited. Qiming GP IV, L.P. is the general partner of Qiming Venture Partners IV, L.P., which holds approximately 96.94% of the equity interest of QM11 Limited. QM11 Limited is the owner of 66,329,320 Ordinary Shares, which is consisted of 1,268,000 ADSs and 53,649,320 ordinary shares. Note to Row (11): The percentage is calculated based upon an aggregate of 1,110,783,740 Ordinary Shares outstanding as of June 30, 2025, which is based on the information disclosed by the Issuer on July 7, 2025.


SCHEDULE 13G



Comment for Type of Reporting Person:  Note to Row (6) (8) and (9): As of the date of this 13G/A filing, Qiming Managing Directors Fund IV, L.P. holds approximately 3.06% of the equity interest of QM11 Limited, which is the owner of 66,329,320 Ordinary Shares (in the form of 1,268,000 ADSs and 53,649,320 ordinary shares). Note to Row (11): The percentage is calculated based upon an aggregate of 1,110,783,740 Ordinary Shares outstanding as of June 30, 2025, which is based on the information disclosed by the Issuer on July 7, 2025.


SCHEDULE 13G



Comment for Type of Reporting Person:  Note to Row (6) (8) and (9): As of the date of this 13G/A filing, Qiming GP IV, L.P. is the general partner of Qiming Venture Partners IV, L.P., which owns approximately 96.94% of the equity interest of QM11 Limited, which is the owner of 66,329,320 Ordinary Shares (in the form of 1,268,000 ADSs and 53,649,320 ordinary shares). Note to Row (11): The percentage is calculated based upon an aggregate of 1,110,783,740 Ordinary Shares outstanding as of June 30, 2025, which is based on the information disclosed by the Issuer on July 7, 2025.


SCHEDULE 13G



Comment for Type of Reporting Person:  Note to Row (6) (8) and (9): As of the date of this 13G/A filing, Qiming Venture Partners IV, L.P. holds approximately 96.94% of the equity interest of QM11 Limited, which is the owner of 66,329,320 Ordinary Shares (in the form of 1,268,000 ADSs and 53,649,320 ordinary shares). Note to Row (11): The percentage is calculated based upon an aggregate of 1,110,783,740 Ordinary Shares outstanding as of June 30, 2025, which is based on the information disclosed by the Issuer on July 7, 2025.


SCHEDULE 13G



Comment for Type of Reporting Person:  Note to Row (11): The percentage is calculated based upon an aggregate of 1,110,783,740 Ordinary Shares outstanding as of June 30, 2025, which is based on the information disclosed by the Issuer on July 7, 2025.


SCHEDULE 13G


 
Qiming Corporate GP IV, Ltd.
 
Signature:/s/ Holan Lam
Name/Title:Holan Lam/Authorized Signatory
Date:08/12/2025
 
Qiming Managing Directors Fund IV, L.P
 
Signature:/s/ Holan Lam
Name/Title:Holan Lam/Authorized Signatory
Date:08/12/2025
 
Qiming GP IV, L.P
 
Signature:/s/ Holan Lam
Name/Title:Holan Lam/Authorized Signatory
Date:08/12/2025
 
Qiming Venture Partners IV, L.P.
 
Signature:/s/ Holan Lam
Name/Title:Holan Lam/Authorized Signatory
Date:08/12/2025
 
QM11 Limited
 
Signature:/s/ Holan Lam
Name/Title:Holan Lam/Authorized Signatory
Date:08/12/2025
Exhibit Information

Exhibit A Joint Filing Agreement dated February 13, 2019 https://www.sec.gov/Archives/edgar/data/1704292/000095010319001958/dp102255_sc13ga-zai.htm

primary_doc.xml